Zorubicin

CAS: 54083-22-6

Ref. 3D-FZ36706

Produktinformation

• Name: Zorubicin
• Synonyme: Benzoic acid, 2-[1-[(2S,4S)-4-[(3-amino-2,3,6-trideoxy-α-<span class="text-smallcaps">L</span>-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]ethylidene]hydrazide, Benzoic acid, [1-[(2S,4S)-4-[(3-amino-2,3,6-trideoxy-α-<span class="text-smallcaps">L</span>-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]ethylidene]hydrazide, Benzoic acid, [1-[4-[(3-amino-2,3,6-trideoxy-α-<span class="text-smallcaps">L</span>-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]ethylidene]hydrazide, (2S-cis)-, Daunomycin benzoylhydrazone, Mcmc 4222, Rubidazon

Beschreibung

Zorubicin is a drug that belongs to the group of anthracyclines. It has been used in the treatment of various solid tumours, including breast cancer and skin cancer. Zorubicin inhibits the growth of cells by binding to DNA and inhibiting the synthesis of proteins needed for cell growth. Zorubicin also inhibits energy metabolism by preventing ATP production and can cause cardiac toxicity, as well as congestive heart failure. This drug also causes damage to erythrocytes and leukocytes through its hydrophobic effect. Zorubicin is a disulfide-containing compound with a molecular weight of 727 Da. The compound is highly hydrophobic, which may be due to its ability to form hydrogen bonds with other molecules and water molecules.

• Marke: Biosynth

Chemische Eigenschaften

• Reinheit: Min. 95%